Background With emerging basic research evidence suggesting that fibroblast growth factor
(FGF) 21 is a catabolic molecule on muscle metabolism, we aimed to analyze the serum …

Background despite of the beneficial effects of fibroblast growth factor (FGF) 21 in several
metabolic diseases, the association of plasma FGF21 with muscle mass and muscle …

Aim Serum fibroblast growth factor (FGF)19 and FGF21 levels have been reported to be
associated with muscle hemostasis. This study aims to explore the relationship between the …

Background FGF23 has been associated with frailty and functional performance in older
individuals, but the association to sarcopenia is unknown. Objectives To investigate the …

Background Circulating FGF21 levels are commonly elevated in disease states. There is
limited information regarding concentrations of circulating FGF21 in the absence of disease …

OBJECTIVE Fibroblast growth factor-21 (FGF-21) is a potent metabolic regulator, which in
animal models has been shown to improve glucose metabolism and insulin sensitivity …

Aims/hypothesis Pharmacological doses of FGF21 improve glucose tolerance, lipid
metabolism and energy expenditure in rodents. Induced expression and secretion of FGF21 …

Fibroblast growth factor (FGF) 21 has various functions, including glucose and lipid
metabolism. This cross-sectional study aimed to investigate specific conditions that might …

In animals, high fibroblast growth factor 21 (FGF21) states improve insulin resistance but
induce bone loss. Whether FGF21 relates to bone mineral density (BMD) is unknown in …

Objective Fibroblast growth factor 21 (FGF21) levels have been linked with beneficial effects
on glucose and lipid metabolism in animals. It is elevated in humans with the metabolic …